YD Bio YDES
NASDAQ YDES
$6.12 +0.20 (+3.38%)
At close: Oct 19, 2026 · 4:00 PM EDT

YD Bio (YDES) Receivables - Net (2024 - 2026)

Updated

YD Bio's Receivables - Net was $223,067 in the quarter ended Jun 30, 2026, up 119.9% from $101,430 a year earlier.

Analysis

YD Bio (YDES) Receivables - Net (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, Receivables - Net at YD Bio came in at $167,477, up 93.4% from the prior year.

  • In earlier years, Receivables - Net was $86,582 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn
10 YD Bio 417.66 Mn 405.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 223,067.00
Dec 31, 2025 167,477.00
Jun 30, 2025 101,430.00
Dec 31, 2024 86,582.00
API Access

YD Bio Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=YDES&period=max&api_key=YOUR_API_KEY